Poultry diagnostics market expected to grow significantly due to increased awareness and regulatory standards.

From GlobeNewswire: 2024-12-11 07:30:00

The Poultry Diagnostics Market was valued at USD 702.5 million in 2023 and is expected to grow at a CAGR of over 10.5% from 2024 to 2032. Tools like molecular diagnostics and serological tests help detect and manage diseases like avian influenza and salmonellosis, crucial for poultry farming’s economic stability.

Increasing awareness of poultry diseases’ impact on food safety and public health is a key driver for market growth. Stricter regulations worldwide are enhancing poultry health standards, leading to increased use of diagnostic tools for early disease detection and prevention, especially for diseases like avian influenza and Salmonella.

The market is divided into product and service components, with diagnostic kits and reagents being popular for their cost-effectiveness and accessibility. ELISA tests dominate the technology segment due to their high sensitivity in detecting a wide array of poultry pathogens, making them a preferred option for reliable diagnostics among poultry producers.

The poultry diagnostics market includes diseases like avian influenza, Newcastle disease, and avian salmonellosis, with the avian influenza segment projected to grow at a rate of 10.8% over the forecast period. Early detection and control of avian influenza are crucial due to its contagious nature and impact on both poultry and human populations.

End users of poultry diagnostics include veterinary hospitals & clinics, poultry farms, and diagnostic laboratories, with the U.S. poultry diagnostics industry expected to reach USD 616.8 million by 2032. Major players in the market include Affinitech, BIOMERIEUX, IDEXX Laboratories, Thermo Fisher Scientific, and Zoetis among others.



Read more at GlobeNewswire: Poultry Diagnostics Market to hit USD 1.7 billion by 2032,